News + Filings Transactions Holdings
All 13F 13D/G Other
|
ORBIMED CAPITAL LLC
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/24/2023 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Prelude Therapeutics Inc
Txns:
| Bought 869,565 shares
@ $5.75, valued at
$5M
|
|
05/08/2023 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.
Txns:
| Bought 83,459 shares
@ $2.75, valued at
$229.5k
Bought 312,991 shares
@ $2.75, valued at
$860.7k
Bought 83,459 shares
@ $2.75, valued at
$229.5k
Bought 490,512 shares
@ $2.82, valued at
$1.4M
Bought 490,511 shares
@ $2.82, valued at
$1.4M
|
|
05/02/2023 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.
Txns:
| Bought 60,998 shares
@ $2.55, valued at
$155.5k
Bought 228,754 shares
@ $2.55, valued at
$583.3k
Bought 60,997 shares
@ $2.55, valued at
$155.5k
Bought 124,544 shares
@ $2.62, valued at
$326.3k
Bought 467,068 shares
@ $2.62, valued at
$1.2M
Bought 124,545 shares
@ $2.62, valued at
$326.3k
Bought 58,826 shares
@ $2.67, valued at
$157.1k
Bought 220,610 shares
@ $2.67, valued at
$589k
Bought 58,826 shares
@ $2.67, valued at
$157.1k
|
|
02/23/2023 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.
Txns:
| Granted 550,000 shares
@ $0 Granted 550,000 shares
@ $0 |
|
07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/08/2022 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns:
| Sold 162,000 shares
@ $20.69, valued at
$3.4M
Sold 171,204 shares
@ $20.69, valued at
$3.5M
Sold 167,800 shares
@ $20.66, valued at
$3.5M
Sold 177,196 shares
@ $20.66, valued at
$3.7M
Sold 97,200 shares
@ $20.71, valued at
$2M
Sold 102,800 shares
@ $20.71, valued at
$2.1M
|
|
03/31/2022 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on PMV Pharmaceuticals, Inc.
Txns:
| Sold 365,000 shares
@ $21.52, valued at
$7.9M
Sold 75,000 shares
@ $22.39, valued at
$1.7M
Sold 34,500 shares
@ $21.17, valued at
$730.4k
|
|
02/15/2022 |
4
| ORBIMED ADVISORS LLC (Director) has filed a Form 4 on Kinnate Biopharma Inc.
Txns:
| Bought 156,000 shares
@ $10.22, valued at
$1.6M
Bought 20,700 shares
@ $9.98, valued at
$206.6k
Bought 10,000 shares
@ $9.89, valued at
$98.9k
Bought 9,000 shares
@ $9.96, valued at
$89.6k
|
|
01/28/2022 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.
Txns:
| Exercised (in-or-at-the-money) 374,962 options to buy
@ $13.2, valued at
$4.9M
Exercised (in-or-at-the-money) 56,244 options to buy
@ $13.2, valued at
$742.4k
Exercised (in-or-at-the-money) 56,244 options to buy
@ $13.2, valued at
$742.4k
|
|
09/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/16/2021 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on IMARA Inc.
Txns:
| Bought 1,666,666 shares
@ $6, valued at
$10M
|
|
02/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/09/2020 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.
Txns:
| Converted 243,494 shares
@ $0 Converted 2,651,042 shares
@ $0 Converted 118,794 shares
@ $0 Converted 50,501 shares
@ $0 Converted 9,461 shares
@ $0 Converted 24,637 shares
@ $0 Converted 243,494 preferred shares
@ $0 Converted 2,651,042 preferred shares
@ $0 Converted 118,398 preferred shares
@ $0 Converted 50,501 preferred shares
@ $0 Converted 9,461 preferred shares
@ $0 |
|
12/08/2020 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Silverback Therapeutics, Inc.
Txns:
| Bought 238,100 shares
@ $21, valued at
$5M
Converted 3,462,737 shares
@ $0 Converted 2,493,741 shares
@ $0 Converted 1,055,287 shares
@ $0 Bought 952,377 shares
@ $21, valued at
$20M
Converted 12,857,142 preferred shares
@ $0 Converted 9,259,259 preferred shares
@ $0 Converted 3,918,279 preferred shares
@ $0 |
|
12/04/2020 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.
Txns:
| Bought 300,000 shares
@ $20, valued at
$6M
Bought 450,000 shares
@ $20, valued at
$9M
|
|
10/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/29/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/29/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/04/2020 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns:
| Bought 382,388 shares
@ $17, valued at
$6.5M
Bought 176,500 shares
@ $17, valued at
$3M
Converted 2,825,603 shares
@ $0 Converted 859,573 shares
@ $0 Converted 429,786 shares
@ $0 Converted 2,825,603 preferred shares
@ $0 Converted 859,573 preferred shares
@ $0 Converted 429,786 preferred shares
@ $0 |
|
01/31/2020 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.
Txns:
| Converted 1,477,320 shares
@ $0 Converted 19,500 options to buy
@ $0 |
|
01/13/2020 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Alector, Inc.
Txns:
| Sold 286,787 shares
@ $19.5, valued at
$5.6M
Sold 91,818 shares
@ $19.5, valued at
$1.8M
Sold 1,392 shares
@ $19.5, valued at
$27.1k
|
|
12/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/09/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|